Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma

Cancer Letters

Volumn 250, Issue 2, 2007, Pages 284-291

  Ip, Wai Ki ^a   Lai, Paul B S ^a   Wong, Navy L Y ^a   Sy, Shirley M H ^a   Beheshti, Ben ^b   Squire, Jeremy A ^b   Wong, Nathalie ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Array based CGH; cDNA microarray; Hepatocellular carcinoma; PEG10

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEG10 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UPREGULATION; VALIDATION PROCESS;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA PRIMERS; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 34047148845     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.10.012     Document Type: Article

References (28)

1. Lichter P., Joos S., Bentz M., and Lampel S. Comparative genomic hybridization: uses and limitations. Semin. Hematol. 37 (2000) 348-357
2. Inazawa J., Inoue J., and Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci. 95 (2004) 559-563
3. Garnis C., Coe B.P., Zhang L., Rosin M.P., and Lam W.L. Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23 (2004) 2582-2586
4. Westbrook T.F., Martin E.S., Schlabach M.R., Leng Y., Liang A.C., Feng B., Zhao J.J., Roberts T.M., Mandel G., Hannon G.J., Depinho R.A., Chin L., and Elledge S.J. A genetic screen for candidate tumor suppressors identifies REST. Cell 121 (2005) 837-848
5. Platzer P., Upender M.B., Wilson K., Willis J., Lutterbaugh J., Nosrati A., Willson J.K., Mack D., Ried T., and Markowitz S. Silence of chromosomal amplifications in colon cancer. Cancer Res. 62 (2002) 1134-1138
6. Tsafrir D., Bacolod M., Selvanayagam Z., Tsafrir I., Shia J., Zeng Z., Liu H., Krier C., Stengel R.F., Barany F., Gerald W.L., Paty P.B., Domany E., and Notterman D.A. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 66 (2006) 2129-2137
7. Yao J., Weremowicz S., Feng B., Gentleman R.C., Marks J.R., Gelman R., Brennan C., and Polyak K. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 66 (2006) 4065-4078
8. Li R., Wang H., Bekele B.N., Yin Z., Caraway N.P., Katz R.L., Stass S.A., and Jiang F. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25 (2006) 2628-2635
9. Saramaki O.R., Porkka K.P., Vessella R.L., and Visakorpi T. Genetic aberrations in prostate cancer by microarray analysis. Int. J. Cancer 119 (2006) 1322-1329
10. Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T., Takemoto N., Tangoku A., Hamada K., Nakayama H., Miyamoto T., Uchimura S., and Hamamoto Y. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 62 (2002) 3939-3944
11. Crawley J.J., and Furge K.A. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol. 3 (2002) RESEARCH0075
12. Chung E.J., Sung Y.K., Farooq M., Kim Y., Im S., Tak W.Y., Hwang Y.J., Kim Y.I., Han H.S., Kim J.C., and Kim M.K. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol. Cells 14 (2002) 382-387
13. Chen X., Cheung S.T., So S., Fan S.T., Barry C., Higgins J., Lai K.M., Ji J., Dudoit S., Ng I.O., Van De Rijn M., Botstein D., and Brown P.O. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13 (2002) 1929-1939
14. Xu X.R., Huang J., Xu Z.G., Qian B.Z., Zhu Z.D., Yan Q., Cai T., Zhang X., Xiao H.S., Qu J., Liu F., Huang Q.H., Cheng Z.H., Li N.G., Du J.J., Hu W., Shen K.T., Lu G., Fu G., Zhong M., Xu S.H., Gu W.Y., Huang W., Zhao X.T., Hu G.X., Gu J.R., Chen Z., and Han Z.G. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. USA 98 (2001) 15089-15094
15. Sy S.M., Wong N., Lai P.B., To K.F., and Johnson P.J. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod. Pathol. 18 (2005) 686-692
16. Li C.M., Margolin A.A., Salas M., Memeo L., Mansukhani M., Hibshoosh H., Szabolcs M., Klinakis A., and Tycko B. PEG10 is a c-MYC target gene in cancer cells. Cancer Res. 66 (2006) 665-672
17. Okabe H., Satoh S., Furukawa Y., Kato T., Hasegawa S., Nakajima Y., Yamaoka Y., and Nakamura Y. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 63 (2003) 3043-3048
18. Tsou A.P., Chuang Y.C., Su J.Y., Yang C.W., Liao Y.L., Liu W.K., Chiu J.H., and Chou C.K. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J. Biomed. Sci. 10 (2003) 625-635
19. Chan K.Y., Wong N., Lai P.B., Squire J.A., Macgregor P.F., Beheshti B., Albert M., To K.F., and Johnson P.J. Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma. Int. J. Cancer 114 (2005) 902-908
20. Pang E., Wong N., Lai P.B., To K.F., Lau W.Y., and Johnson P.J. Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines. Genes Chromosomes Cancer 33 (2002) 150-159
21. Wong N., Chan K.Y., Macgregor P.F., Lai P.B., Squire J.A., Beheshti B., Albert M., and Leung T.W. Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells. Clin. Cancer Res. 11 (2005) 1319-1326
22. Beheshti B., Braude I., Marrano P., Thorner P., Zielenska M., and Squire J.A. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 5 (2003) 53-62
23. Ono R., Kobayashi S., Wagatsuma H., Aisaka K., Kohda T., Kaneko-Ishino T., and Ishino F. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics 73 (2001) 232-237
24. Lux A., Beil C., Majety M., Barron S., Gallione C.J., Kuhn H.M., Berg J.N., Kioschis P., Marchuk D.A., and Hafner M. Human retroviral gag- and gag-pol-like proteins interactwith the transforming growth factor-beta receptor activin receptor-like kinase 1. J. Biol. Chem. 280 (2005) 8482-8493
25. Ono R., Nakamura K., Inoue K., Naruse M., Usami T., Wakisaka-Saito N., Hino T., Suzuki-Migishima R., Ogonuki N., Miki H., Kohda T., Ogura A., Yokoyama M., Kaneko-Ishino T., and Ishino F. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat. Genet. 38 (2006) 101-106
26. Hu C., Xiong J., Zhang L., Huang B., Zhang Q., Li Q., Yang M., Wu Y., Wu Q., Shen Q., Gao Q., Zhang K., Sun Z., Liu J., Jin Y., and Tan J. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. Cell Mol. Immunol. 1 (2004) 280-294
27. Feitelson M.A. c-myc overexpression in hepatocarcinogenesis. Hum. Pathol. 35 (2004) 1299-1302
28. Huang J., Sheng H.H., Shen T., Hu Y.J., Xiao H.S., Zhang Q., Zhang Q.H., and Han Z.G. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma. FEBS Lett. 580 (2006) 3571-3581